UPDATED – Hawaii Cannabis Science Dinner & Dialogue Panel to Discuss Company’s Research on the Endocannabinoid System for Breakthrough Therapies LOS ANGELES, March 23, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (“CURE” or the “Company”) (OTC:CURR), an innovative drug delivery and development company, today announced that the Company will...

CURE Pharmaceutical to Participate in Hawaiian Cannabis Science Dinner & Dialogue Panel to Discuss Company’s Research on the Endocannabinoid System for Breakthrough Therapies LOS ANGELES, March 23, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (“CURE” or the “Company”) (OTC:CURR), an innovative drug delivery and development company, today announced that the Company will...

CURE Pharmaceutical Appoints CannaKids CEO and Cannabis Cancer Advocate Tracy Ryan to Advisory Board OXNARD, Calif., June 27, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development...